InvestorQ : How do you see the latest drug approval for Cadila impacting the stock price?
prachi Patwardhan made post

How do you see the latest drug approval for Cadila impacting the stock price?

Answer
user profile image
sara Kunju answered.
3 weeks ago


Recently, Zydus Cadila got USFDA approval for the orthostatic hypotension drug. This is meant for people who find their blood pressure levels dropping the moment they stand up on their feet and the drug is meant to address this specific problem.

The FDA of the US has approved the company’s application to market Midodrine Hydrochloride. This is used to treat the affliction of dropping blood pressure when people stand and this medical condition is popularly referred to as orthostatic hypotension.

Currently, Cadila has secured FDA approval to launch 2.5 mg, 5 mg and 10 mg tablets in the US markets. The drugs will be manufactured in the SEZ manufacturing facility near Ahmadabad, where its principal manufacturing locations are located.

The Coronavirus has been a kind of blessing in disguise for the Indian pharma sector as approvals got speeded up. Till date, in the last 17 years, the company has secured 298 approvals and has so far filed 390 Abbreviated New Drug Applications or ANDAs with FDA.